Ozempic Vs. Glucose Monitors (feat. Sharam Fouladgar-Mercer) #685

Yet more GLP1 news this week.  People regain on average 60% of their lost weight within a year of stopping GLP-1 drugs — and the regained weight may be disproportionately fat rather than muscle.  So are a tool that biohackers have known about for years - CGMs - the answer?  Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared glucose system for weight management. Follow Sharam Fouladgar-Mercer on LinkedIn.